High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
Mastaneh MohammadiFarhad ShahramHormoz ShamsMassoomeh AkhlaghiFarimah AshoftehFereydoun DavatchiPublished in: International journal of rheumatic diseases (2017)
Adding high-dose intravenous steroid pulse therapy to conventional combination therapy for severe ocular lesions of BD may cause better improvement on VA and fewer flares during the first 6 months of treatment.